Connection
Alexandra McMellen to Neoplasm Grading
This is a "connection" page, showing publications Alexandra McMellen has written about Neoplasm Grading.
|
|
Connection Strength |
|
|
|
|
|
0.041 |
|
|
|
-
Watson ZL, Yamamoto TM, McMellen A, Kim H, Hughes CJ, Wheeler LJ, Post MD, Behbakht K, Bitler BG. Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma. Clin Epigenetics. 2019 11 27; 11(1):165.
Score: 0.041